Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Endocrinol Diabetes Metab · 2025 · PMC12457091 · PMID 40988099

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

No conclusive evidence links GLP‐1 RA use to an increased risk of pancreatic cancer, but a slightly significant association was found when stratified with background medications.

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.